Fig. 3From: Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover studyPlasma arginine vasopressin following 18 mg m−2 cisplatin i.v. Timecourse of change in plasma AVP following 18 mg m−2 cisplatin i.v. comparing placebo to each of the antiemetic treatment groups. Values presented as mean + SEM, n = 8 per group, except metoclopramide group where n = 7. Significant differences between placebo and anti-emetic treated groups: mixed linear model (**P < 0.01, *** P < 0.001)Back to article page